Amneal
0
Generic Drugmaker Amneal Clocks Mixed Q4 Earnings, Plans Expansion In High-Growth Areas Like Weight Loss Products, Biosimilars – Amneal Pharmaceuticals (NASDAQ:AMRX)
0

Generic Drugmaker Amneal Clocks Mixed Q4 Earnings, Plans Expansion In High-Growth Areas Like Weight Loss Products, Biosimilars – Amneal Pharmaceuticals (NASDAQ:AMRX)

On Friday, Amneal Pharmaceuticals Inc. AMRX reported fourth-quarter adjusted EPS of 12 cents, down from 14 cents a year ago and missing the consensus of ...

admin admin February 28, 2025
READ MORE +

No widgets added. You can disable footer widget area in theme options - footer options

Som2ny Network
Logo
Compare items
  • Total (0)
Compare
0